Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07074587 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Spinal Stabilization on the Pelvic Floor in Women With Multiple Sclerosis

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Enrolling by Invitation → Completed Final enrollment: 49 participants (planned 36) · Primary completion date changed from estimate of Oct 15, 2027 to Jan 23, 2026 · Eligibility criteria expanded, about 22 words · 1 more Show 4 more changesShow less
    • Final enrollment: 49 participants (planned 36)
    • Primary completion date changed from estimate of Oct 15, 2027 to Jan 23, 2026
    • Eligibility criteria expanded, about 22 words
    • Secondary endpoints: details revised at 11 of 11 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study was to investigate the effects of spinal stabilization exercises focusing on the pelvic floor on core stability, urinary symptoms and pelvic floor muscle function in women with Multiple Sclerosis and lower urinary tract symptoms. Participants will be randomly assigned to a control group that receives pelvic floor muscle exercises only or an experimental group that receives both pelvic floor muscle exercises and spinal stabilization exercise focused on the pelvic floor. Outcome measures will be assessed pre- and post-intervention using validated instruments.
Trial Details
NCT Number NCT07074587
Lead Sponsor Abant Izzet Baysal University
Conditions Multiple Sclerosis, Urinary Incontinence, Lower Urinary Tract Symptoms
Enrollment 49 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov